Investment
Features
FeesSafety
Academy
More
Pluang+

Compare GTS Internasional Tbk. (GTSI) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

GTS Internasional Tbk.Trade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

GTS Internasional Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? GTS Internasional Tbk. trades at Rp134 (market cap 2.2T, 19.55M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp246 (market cap 167.37B, 71K 24h volume). The key difference: GTS Internasional Tbk. is far larger — about 13.1× Brigit Biofarmaka Teknologi Tbk.'s market cap, and GTS Internasional Tbk. is more actively traded (19.55M versus 71K). Which is the better fit depends on your goals.

GTSIOBAT
Market Cap
2.2T167.37B
Volume
19.55M71K
Lot
195.46K710
Turnover
2.63B17.51M
Average Price
134.62246.63
Value
2.63B17.51M
Indicative Equilibrium Price
134246
Indicative Equilibrium Volume
7.31K1

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

GTSI
View details
OBAT
View details

About GTS Internasional Tbk.

PT GTS Internasional Tbk (the “Company”) was established based on Notarial Deed No. 32 dated June 29, 2012 of Martina, S.H. The Company started its commercial operations in August 2019. The Company’s parent entity is PT Hateka Trans Internasional and ultimate parent entity is PT Humpuss Intermoda Transportasi Tbk.

Read more on GTSI

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT